UPDATE on RT001 Clinical Trials for PSP

UPDATE on RT001 Clinical Trials for PSP

From Sarah at Retrotope regarding RT001 Clinical Trials for PSP!

Do not lose hope. Retrotope is in the process of developing drugs to treat a variety of neurological diseases, and PSP is a disease that we intend to target. We have treated a few patients in the US with our investigational drug candidate RT001 in a small Expanded Access cohort, and we have seen encouraging results. These results have prompted us to plan a formal clinical trial for PSP and this is likely to begin sometime in summer 2020.

The trial will take place at several centers within the United States. If a patient with PSP meets all trial criteria and is willing and able to travel every few months to a U.S. medical center that is participating in the trial, she or he may be able to enroll in our study.

As the trial start nears, a formal listing regarding the trial and participating clinical trial sites will be posted on https://clinicaltrials.gov/. With your permission, I can additionally add you to my list of patients/families to notify at the appropriate time. Please let me know.

Kind regards,
Sarah

Sarah Endemann, MSc, CCRC
Clinical Coordinator
Retrotope, Inc.
4300 El Camino Real, Ste. 201
Los Altos, CA 94022
Tel: 619.206.5944
Fax: 650.209.5007
sarah@retrotope.com
www.retrotope.com

Back to blog

Leave a comment

Please note, comments need to be approved before they are published.

PSP Awareness Shop

Make a purchase with purpose. Each sale supports the fight against Atypical Parkinsonism through the Coleen Cunningham Foundation for PSP Awareness!

Shop Now
  • Atypical Parkinsonism: Navigating the Unknown and Embracing What's Known

    Atypical Parkinsonism: Navigating the Unknown a...

    Laura Louizos

    Atypical Parkinsonism is a group of neurological disorders that share some symptoms with Parkinson's disease but differ in certain key aspects, including their progression and response to treatment. For individuals...

    Atypical Parkinsonism: Navigating the Unknown a...

    Laura Louizos

    Atypical Parkinsonism is a group of neurological disorders that share some symptoms with Parkinson's disease but differ in certain key aspects, including their progression and response to treatment. For individuals...

  • Tim Talks - November 30th, 7-9 PM Eastern Time

    Tim Talks - November 30th, 7-9 PM Eastern Time

    Laura Louizos

    Join us for an inspiring evening with our special guest, Tim Brown – a passionate PSP warrior! 🔹 First Hour: Dive into a Q&A session with Tim, where he’ll share his...

    Tim Talks - November 30th, 7-9 PM Eastern Time

    Laura Louizos

    Join us for an inspiring evening with our special guest, Tim Brown – a passionate PSP warrior! 🔹 First Hour: Dive into a Q&A session with Tim, where he’ll share his...

  • A Heartfelt Thank You to Our Support Group Members

    A Heartfelt Thank You to Our Support Group Members

    Laura Louizos

    As we close the curtains on this year, I want to extend a massive thank you to each and every one of you who have been a part of our...

    A Heartfelt Thank You to Our Support Group Members

    Laura Louizos

    As we close the curtains on this year, I want to extend a massive thank you to each and every one of you who have been a part of our...

  • Caregiver's Corner: Supporting Loved Ones with Atypical Parkinsonism

    Caregiver's Corner: Supporting Loved Ones with ...

    Laura Louizos

    Atypical Parkinsonism encompasses a group of neurodegenerative disorders that share some symptoms with Parkinson's disease but have distinct characteristics and challenges. These conditions, including Multiple System Atrophy (MSA), Progressive Supranuclear...

    Caregiver's Corner: Supporting Loved Ones with ...

    Laura Louizos

    Atypical Parkinsonism encompasses a group of neurodegenerative disorders that share some symptoms with Parkinson's disease but have distinct characteristics and challenges. These conditions, including Multiple System Atrophy (MSA), Progressive Supranuclear...

1 of 4